Were All Carbapenemases Created Equal? Treatment of NDM-producing Extensively Drug-resistant Enterobacteriaceae: a Case Report and Literature Review
Overview
Affiliations
Purpose: There is currently a paucity of published literature focused on the treatment of infections caused by NDM-producing organisms.
Methods: We describe a case of a bacteraemia caused by an extensively drug-resistant (XDR) New Delhi metallo-β-lactamase (NDM)-producing Serratia marcescens and review the treatment options for XDR NDM-producing Enterobacteriaceae.
Results: Infections caused by New Delhi beta-lactamase (NDM)-producing Enterobacteriaceae are becoming increasingly prevalent worldwide. The presence of the enzyme results in multidrug-resistant and extensively drug-resistant phenotypes which often pose a treatment challenge. Despite this challenge, case reports and series have demonstrated good clinical outcomes with numerous treatment options in comparison to infections due to KPC-producing Enterobacteriaceae.
Conclusions: Further good-quality research focused on the treatment of NDM-producing Enterobacteriaceae is warranted.
Abdelraouf K, Gill C, Gethers M, Tiseo G, Barnini S, Falcone M Open Forum Infect Dis. 2024; 11(5):ofae228.
PMID: 38813259 PMC: 11134298. DOI: 10.1093/ofid/ofae228.
First case of bloodstream infection caused by NDM-positive Escherichia hermannii.
Lu B, Wang B, Pan X, Liu C, Jin C, Shi Y BMC Infect Dis. 2023; 23(1):355.
PMID: 37231346 PMC: 10214694. DOI: 10.1186/s12879-023-08336-3.
Simon M, Gerlach R, Pfeifer Y, Pfennigwerth N, Gatermann S, Schroder A Front Microbiol. 2022; 13:977330.
PMID: 36483203 PMC: 9723239. DOI: 10.3389/fmicb.2022.977330.
Greybe L, Nuttall J, Brink A, Tootla H S Afr J Infect Dis. 2022; 37(1):440.
PMID: 35935170 PMC: 9350446. DOI: 10.4102/sajid.v37i1.440.
Kaewnirat K, Chuaychob S, Chukamnerd A, Pomwised R, Surachat K, Phoo M Infect Drug Resist. 2022; 15:1777-1791.
PMID: 35437346 PMC: 9013254. DOI: 10.2147/IDR.S357965.